Microalbuminuria Global Clinical Trials Review, H2, 2015

1
Microalbuminuria Global Clinical Trials Review,
H2, 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Microalbuminuria Global Clinical Trials Review,
  H2, 2015 provides an overview of Microalbuminuria
  clinical trials scenario. This report provides
  top line data relating to the clinical trials on
  Microalbuminuria. Report includes an overview of
  trial numbers and their average enrollment in top
  countries conducted across the globe. The report
  offers coverage of disease clinical trials by
  region, country (G7 E7) , phase, trial status,
  end points status and sponsor type. Report also
  provides prominent drugs for in-progress trials
  (based on number of ongoing trials) .
• Scope
• The report provides a snapshot of the global
  clinical trials landscape
• Report provides top level data related to the
  clinical trials by Region, Country (G7 E7) ,
  Trial Status, Trial Phase, Sponsor Type and End
  point status
• The report reviews top companies involved and
  enlists all trials (Trial title, Phase, and
  Status) pertaining to the company
• The report provides all the unaccomplished trials
  (Terminated, Suspended and Withdrawn) with reason
  for unaccomplishment
• The Report provides enrollment trends for the
  past five years
• Report provides latest news for the past three
  months
• Read More At http//www.researchbeam.com/microa
  lbuminuria-global-clinical-trials-review-h2-2015-m
  arket

3


Table of Content
Table of ContentsTable of Contents 2List of
Tables 4List of Figures 5Introduction
6Microalbuminuria 6Report Guidance 6Clinical
Trials by Region 7Clinical Trials and Average
Enrollment by Country 8Top Five Countries
Contributing to Clinical Trials in Asia-Pacific
10Top Five Countries Contributing to Clinical
Trials in Europe 11Top Countries Contributing to
Clinical Trials in North America 12Top Countries
Contributing to Clinical Trials in Middle East
and Africa 13Top Countries Contributing to
Clinical Trials in Central and South America
14Clinical Trials by G7 Countries Proportion of
Microalbuminuria to Genito Urinary System And Sex
Hormones Clinical Trials 15Clinical Trials by
Phase in G7 Countries 16Clinical Trials in G7
Countries by Trial Status 17Clinical Trials by
E7 Countries Proportion of Microalbuminuria to
Genito Urinary System And Sex Hormones Clinical
Trials 18Clinical Trials by Phase in E7
Countries 19Clinical Trials in E7 Countries by
Trial Status 20
4


Table of Content
Clinical Trials by Phase 21In Progress Trials by
Phase 22Clinical Trials by Trial Status
23Clinical Trials by End Point Status
24Unaccomplished Trials of Microalbuminuria
25Subjects Recruited Over a Period of Time
27Clinical Trials by Sponsor Type 28Prominent
Sponsors 29Top Companies Participating in
Microalbuminuria Therapeutics Clinical Trials
30Prominent Drugs 31Clinical Trial Profiles
32Clinical Trial Overview of Top Companies
32Steno Diabetes Center A/S 32Clinical Trial
Overview of Steno Diabetes Center A/S 32Novartis
AG 33Clinical Trial Overview of Novartis AG
33Takeda Pharmaceutical Company Limited
34Clinical Trial Overview of Takeda
Pharmaceutical Company Limited 34Sanofi
35 Enquire At http//www.researchbeam.com/micro
albuminuria-global-clinical-trials-review-h2-2015-
market/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/microalbuminuria-globa
l-clinical-trials-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com